Onur, I. D. Et Al. 2024. Evaluating the effectiveness of the Charlson Comorbidity Index in predicting immune checkpoint inhibitor-related adverse events. IMMUNOTHERAPY , vol.16 , 295-303.

Onur, I. D., MUTLU, E., Sertesen, E., Onder, T., Duran, A. O., & İNANÇ, M., (2024). Evaluating the effectiveness of the Charlson Comorbidity Index in predicting immune checkpoint inhibitor-related adverse events. IMMUNOTHERAPY , vol.16, 295-303.

Onur, Ilknur Et Al. "Evaluating the effectiveness of the Charlson Comorbidity Index in predicting immune checkpoint inhibitor-related adverse events," IMMUNOTHERAPY , vol.16, 295-303, 2024

Onur, Ilknur D. Et Al. "Evaluating the effectiveness of the Charlson Comorbidity Index in predicting immune checkpoint inhibitor-related adverse events." IMMUNOTHERAPY , vol.16, pp.295-303, 2024

Onur, I. D. Et Al. (2024) . "Evaluating the effectiveness of the Charlson Comorbidity Index in predicting immune checkpoint inhibitor-related adverse events." IMMUNOTHERAPY , vol.16, pp.295-303.

@article{article, author={Ilknur Deliktas Onur Et Al. }, title={Evaluating the effectiveness of the Charlson Comorbidity Index in predicting immune checkpoint inhibitor-related adverse events}, journal={IMMUNOTHERAPY}, year=2024, pages={295-303} }